Joshua W. Russo - Concepedia

Author

Joshua W. Russo

Beth Israel Deaconess Medical Center ORCID

Also Known As

Joshua Russo, Joshua W Russo, Joshua W. Russo

118

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University Dana-Farber Cancer Institute Fred Hutch Cancer Center National Cancer Institute

About

Joshua W. Russo is an author at Beth Israel Deaconess Medical Center specializing in tumor biology, radiation oncology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	354
2	Cell Biology	3	3	354
3	Cell Signaling	2	2	114
4	Natural Sciences	1	1	36
5	Molecular Biology	1	1	36

Joshua W. Russo

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer Adam Sharp, Ilsa M. Coleman, Wei Yuan, Journal of Clinical Investigation	2018	377
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer Zeda Zhang, Wouter R. Karthaus, Young Sun Lee, Cancer Cell MedicineTumor SuppressorProstatic DiseaseCancer BiologyCell Biology	2020	240
Transcriptional mediators of treatment resistance in lethal prostate cancer Meng Xiao He, Michael S. Cuoco, Jett Crowdis, Nature Medicine	2021	186
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide Carla Calagua, Joshua W. Russo, Yue Sun, Clinical Cancer Research	2017	88
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors André Richters, Shelby K. Doyle, David B. Freeman, Cell chemical biology Androgen ReceptorAndrogen Receptor-driven TranscriptionTumor BiologyTranscriptional RegulationReceptor Tyrosine Kinase	2020	78
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Cancer Research	2018	72
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer Haiyang Guo, Yiming Wu, Mannan Nouri, Nature Communications	2021	72
CCN5: biology and pathophysiology Joshua W. Russo, John J. Castellot Journal of Cell Communication and Signaling	2010	64
Downregulation of <i>Dipeptidyl Peptidase 4</i> Accelerates Progression to Castration-Resistant Prostate Cancer Joshua W. Russo, Ce Gao, Swati S. Bhasin, Cancer Research	2018	58
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4 Adam G. Sowalsky, Haydn Kissick, Sean Gerrin, Clinical Cancer Research	2017	47

Page 1